Investing.com - Abbott Labs (NYSE:ABT) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $0.98 on revenue of $8.85B. Analysts polled by Investing.com anticipated EPS of $0.9 on revenue of $8.5B.
Abbott Labs shares are down 6% from the beginning of the year and are trading at $110.32 , down-from-52-week-high.They are under-performing the S&P 500 which is up 6.57% from the start of the year.
Abbott Labs shares gained 1.81% in pre-market trade the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.63 on revenue of $8.52B, compared to forecast for EPS of $4.31 on revenue of $7.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar